Skip to main content

Peer Review reports

From: DLBCL with amplification of JAK2/PD-L2 exhibits PMBCL-like CNA pattern and worse clinical outcome resembling those with MYD88 L265P mutation

Original Submission
11 Mar 2020 Submitted Original manuscript
20 Mar 2020 Author responded Author comments - Xuemin Xue
Resubmission - Version 2
20 Mar 2020 Submitted Manuscript version 2
4 May 2020 Reviewed Reviewer Report
11 May 2020 Reviewed Reviewer Report
14 Jun 2020 Author responded Author comments - Xuemin Xue
Resubmission - Version 3
14 Jun 2020 Submitted Manuscript version 3
10 Aug 2020 Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
11 Aug 2020 Editorially accepted
27 Aug 2020 Article published 10.1186/s12885-020-07293-3

You can find further information about peer review here.

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us